Moreover, we have demonstrated that miR‐4524b‐5p targets ALDH1A3 to reduce proliferation and radioresistance in GBM by regulating the PI3K/AKT/mTOR signaling pathway and glycolytic activity. This evidence concerns the gene AKT1 and glioblastoma.